GC
RMD icon

Greenvale Capital’s ResMed RMD Stock Holding History

Greenvale Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-700,000
Closed -$171M – 19
2024
Q3 		$171M Sell
700,000
-25,000
-3% -$5.59M 9.76% 4
2024
Q2 		$139M Buy
725,000
+275,000
+61% +$55.8M 8.72% 5
2024
Q1 		$89.1M Sell
450,000
-101,901
-18% -$18.7M 6.84% 5
2023
Q4 		$94.9M Buy
551,901
+366,901
+198% +$56.4M 8.08% 7
2023
Q3 		$27.4M Buy
+185,000
New +$33.5M 2.4% 14

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Greenvale Capital's RMD Position: Q4 2024 in Review

Greenvale Capital sold out of ResMed (RMD) in Q4 2024, closing a stake of 700,000 shares — an estimated $171M sold.

Greenvale Capital first reported a position in RMD in Q3 2023 and held it in 5 quarters. The position peaked at $171M in Q3 2024. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Greenvale Capital reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • Greenvale Capital sold 700,000 ResMed shares in Q4 2024, an estimated $171M.
  • Greenvale Capital first reported a position in ResMed in Q3 2023 and held it in 5 quarters.
  • Greenvale Capital's ResMed position peaked at $171M in Q3 2024.
  • 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Greenvale Capital's 13F filing for Q4 2024, filed 14 Feb 2025.